<DOC>
	<DOCNO>NCT00407680</DOCNO>
	<brief_summary>To observe effect intensive medical treatment type 2 diabetic patient hypertension : discover whether intensive medical treatment improve proteinuria , difference clinical meaning responder non-responder ( criterion : 50 % reduce proteinuria continue 6 month observation period . )</brief_summary>
	<brief_title>Intensive Medical Treatment Nephropathy Caused Type 2 Diabetes With Hypertension</brief_title>
	<detailed_description>It report risk cardiovascular event occur 1.78 time high patient diabetic nephropathy ( DN ) patient without DN . It also report angiotensin II receptor blockade ( ARB ) prevent progression DN diabetic patient early phase nephropathy beyond blood pressure lower effect . The guideline Japanese Society Hypertension 2004 recommend necessary control blood pressure ( BP ) 130/80 mmHg diabetic patient . This become universal target BP prevention cardiovascular event hypertensive patient . On study intensive medical treatment [ include angiotensin-converting enzyme inhibitor ( ACEI ) ] , report ACEI prevents progression DN microalbuminuria also decrease proteinuria &lt; 1 g/day nephrotic syndrome . Therefore , ACEI think effective DN . However , clear whether intensive medical treatment ( include ACEI ) improve nephropathy proteinuria &gt; 1 g/day .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Fluvastatin</mesh_term>
	<criteria>Type 2 diabetic patient hypertension , 5 criterion list : 1 . Age 20 year 2 . Blood pressure &gt; 125/75 mmHg 3 . Urinary protein creatinine ratio 1g/gãƒ»cr Urinary protein &gt; 1 g/day 4 . Presence diabetic retinopathy 5 . Already perform dietary management There limitation serum creatinine . BP record 3 time patient seat averaged . The subject study outpatient write informed consent . 1 . Another definable renal disease DN 2 . Collagenosis 3 . Malignant hypertension emergent treatment 4 . Severe hypertension ( diastolic BP &gt; 120 mmHg ) 5 . Severe chronic heart failure acute myocardial infarction past 6 month 6 . Atrial fibrillation severe arrhythmia 7 . Anamnesis cerebrovascular disease neuropathy 8 . Anamnesis anaphylaxis chronic dermatopathy 9 . Severe hepatic disease 10 . Pregnancy 11 . Anamnesis anaphylaxis angiotensin II receptor blocker 12 . Patients judge inapposite attending physician</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Type 2 diabetes mellitus</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Angiotensin II Receptor Blocker</keyword>
	<keyword>Diabetic nephropathy</keyword>
</DOC>